Literature DB >> 10103057

Solution properties of the free and DNA-bound Runt domain of AML1.

M Wolf-Watz1, X Q Xie, M Holm, T Grundström, T Härd.   

Abstract

The Runt domain is responsible for specific DNA and protein-protein interactions in a family of transcription factors which includes human AML1. Structural data on the Runt domain has not yet become available, possibly due to solubility and stability problems with expressed protein fragments. Here we describe the optimization and characterization of a 140-residue fragment, containing the Runt domain of AML1, which is suitable for structural studies. The fragment of AML1 including amino acids 46-185 [AML1 Dm(46-185)] contains a double cysteine-->serine mutation which does not affect Runt domain structure or DNA-binding affinity. Purified AML1 Dm(46-185) is soluble and optimally stable in a buffer containing 200 mm MgSO4 and 20 mm sodium phosphate at pH 6.0. Nuclear magnetic resonance and circular dichroism spectroscopy indicate that the Runt domain contains beta-sheet, but little or no alpha-helical secondary structure elements. The 45 N-terminal residues of AML1 are unstructured and removal of the N-terminal enhances sequence-specific DNA binding. The NMR spectrum of AML1 Dm(46-185) displays a favorable chemical shift dispersion and resolved NOE connectivities are readily identified, suggesting that a structure determination of this Runt domain fragment is feasible. A titration of 15N-labelled AML1 Dm(46-185) with a 14-bp cognate DNA duplex results in changes in the 15N NMR heteronuclear single quantum coherence spectrum which indicate the formation of a specific complex and structural changes in the Runt domain upon DNA binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10103057     DOI: 10.1046/j.1432-1327.1999.00269.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutation.

Authors:  Isaac Ks Ng; Joanne Lee; Christopher Ng; Bustamin Kosmo; Lily Chiu; Elaine Seah; Michelle Meng Huang Mok; Karen Tan; Motomi Osato; Wee-Joo Chng; Benedict Yan; Lip Kun Tan
Journal:  Biomark Res       Date:  2018-05-11

2.  The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element.

Authors:  Junichi Fukunaga; Yusuke Nomura; Yoichiro Tanaka; Ryo Amano; Taku Tanaka; Yoshikazu Nakamura; Gota Kawai; Taiichi Sakamoto; Tomoko Kozu
Journal:  RNA       Date:  2013-05-24       Impact factor: 4.942

3.  RUNX1: an emerging therapeutic target for cardiovascular disease.

Authors:  Alexandra Riddell; Martin McBride; Thomas Braun; Stuart A Nicklin; Ewan Cameron; Christopher M Loughrey; Tamara P Martin
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.